Stocktoria
Cellebrite DI Ltd. CLBT
Nasdaq · XNAS · stock · Services-Prepackaged Software · website · IPO 2021-08-31
Chart by TradingView
4/9
Piotroski F — financial health
2.73
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $475.7M | $401.2M | $325.1M | $270.7M | $246.2M |
| Gross profit | $400.5M | $338.6M | $271.9M | $219.9M | $203.7M |
| Operating income | $66.5M | $56.9M | $33.2M | $1.0M | $13.8M |
| Net income | $78.3M | -$283.0M | -$81.1M | $120.8M | $71.4M |
| Operating cash flow | $173.5M | $132.2M | $102.1M | $20.6M | $36.1M |
| Free cash flow | $160.3M | $123.6M | $96.8M | $13.7M | $30.9M |
| Total assets | $938.9M | $690.6M | $532.9M | $403.3M | $339.8M |
| Total liabilities | $454.5M | $354.5M | $498.7M | $329.4M | $413.1M |
| Shareholders' equity | $484.3M | $336.0M | $34.2M | $73.9M | -$73.3M |
| Ratios | |||||
| Gross margin | 84.2% | 84.4% | 83.6% | 81.3% | 82.7% |
| Operating margin | 14.0% | 14.2% | 10.2% | 0.4% | 5.6% |
| Net margin | 16.5% | -70.5% | -24.9% | 44.6% | 29.0% |
| FCF margin | 33.7% | 30.8% | 29.8% | 5.1% | 12.6% |
| Return on assets | 8.3% | -41.0% | -15.2% | 30.0% | 21.0% |
| Return on equity | 16.2% | -84.2% | -237.1% | 163.5% | -97.3% |
| Current ratio | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 |
| Revenue growth | 18.6% | 23.4% | 20.1% | 9.9% | 26.3% |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.73 (safe)
- Working capital / assets 0.22
- Retained earnings / assets -0.092
- EBIT / assets 0.071
- Equity / liabilities 1.066
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001854587 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.